Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll

September 30, 2013

Firms Ripe for Takeover

Wall Street analysts have labeled seven biotech firms as potential takeover targets this year, as mentioned in GEN’s recent list, “Takeover Targets: Who Is First on the List?”. Of the seven, which do you think is the MOST likely target?

Which company below do you think is the MOST likely to be acquired by a larger biotech partner or pharma giant?

  {{ choice.Percent }}%